Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
a long-chain aldehyde + NAD+ + H2O
a long-chain carboxylate + NADH + 2 H+
-
-
-
?
acetaldehyde + NAD+ + H2O
acetate + NADH + H+
-
-
-
?
arachidic aldehyde + NAD+ + H2O
arachidic acid + NADH
-
-
-
?
behenic aldehyde + NAD+ + H2O
behenic acid + NADH
-
-
-
?
benzaldehyde + NAD+ + H2O
benzoate + NADH + H+
-
-
-
?
cis,cis-9,12-octadecadienal + NAD+ + H2O
cis,cis-9,12-octadecadienoic acid + NADH
cis-11-hexadecenal + NAD+ + H2O
cis-11-hexadecenoic acid + NADH + H+
-
-
-
-
?
cis-9-hexadecenal + NAD+ + H2O
cis-9-hexadecenoic acid + NADH
-
-
-
?
cis-9-octadecenal + NAD+ + H2O
cis-9-octadecenoic acid + NADH
-
-
-
?
crotonaldehyde + NAD+ + H2O
crotonic acid + NADH
-
-
-
?
decanal + NAD+ + H2O
decanoic acid + NADH
-
-
-
?
decanal + NAD+ + H2O
decanoic acid + NADH + H+
-
-
-
-
?
dihydrophytal + NAD+ + H2O
(3R,S,7R,11R)-3,7,11,15-tetramethylhexadecanoic acid + NADH
-
-
-
?
dodecanal + NAD+ + H2O
dodecanoic acid + NADH
-
-
-
?
dodecanal + NAD+ + H2O
dodecanoic acid + NADH + H+
-
-
-
-
?
farnesal + NAD+ + H2O
farnesoic acid + NADH + H+
-
-
-
-
?
glutaraldehyde + NAD+
glutaric acid + NADH
-
-
-
?
heptanal + NAD+ + H2O
heptanoic acid + NADH + H+
-
-
-
-
?
hexadecanal + NAD+ + H2O
hexadecanoic acid + NADH
hexadecanal + NAD+ + H2O
hexadecanoic acid + NADH + H+
-
-
-
-
?
hexanal + NAD+ + H2O
hexanoate + NADH + H+
-
-
-
?
long-chain aldehyde + NAD+
?
-
-
-
-
?
long-chain aldehyde + NAD+ + H2O
long-chain acid anion + NADH
-
-
-
?
long-chain aldehyde + NAD+ + H2O
long-chain carboxylate + NADH
-
-
-
-
?
octadecanal + NAD+ + H2O
octadecanoic acid + NADH
-
-
-
?
octadecanal + NAD+ + H2O
octadecanoic acid + NADH + H+
-
-
-
-
?
octadecanal + NADP+
octadecanoic acid + NADPH + H+
-
-
-
-
r
octanal + NAD+ + H2O
octanoic acid + NADH + H+
pentadecanal + NAD+ + H2O
pentadecanoic acid + NADH
-
-
-
?
phytenal + NAD+
phytenic acid + NADH
propionaldehyde + NAD+ + H2O
propionic acid + NADH
-
-
-
?
pyrenedecanal + NAD+ + H2O
pyrenedecanoic acid + NADH
-
-
-
-
?
tetradecanal + NAD+ + H2O
tetradecanoic acid + NADH
-
-
-
?
tetradecanal + NAD+ + H2O
tetradecanoic acid + NADH + H+
-
-
-
-
?
tetraeicosanal + NAD+ + H2O
tetraeicosanoic acid + NADH
-
-
-
?
trans-2-hexadecenal + NAD+ + H2O
trans-2-decenoic acid + NADH
-
-
-
-
?
additional information
?
-
cis,cis-9,12-octadecadienal + NAD+ + H2O
cis,cis-9,12-octadecadienoic acid + NADH
-
-
-
?
cis,cis-9,12-octadecadienal + NAD+ + H2O
cis,cis-9,12-octadecadienoic acid + NADH
-
major substrate
-
-
?
hexadecanal + NAD+ + H2O
hexadecanoic acid + NADH
-
-
-
?
hexadecanal + NAD+ + H2O
hexadecanoic acid + NADH
-
high activity
-
-
?
octanal + NAD+ + H2O
octanoic acid + NADH + H+
-
-
-
?
octanal + NAD+ + H2O
octanoic acid + NADH + H+
-
-
-
-
?
phytenal + NAD+
phytenic acid + NADH
-
-
-
-
?
phytenal + NAD+
phytenic acid + NADH
-
the enzyme is involved in the breakdown of phytol
-
-
?
additional information
?
-
the C-terminal gatekeeper helix is important for directing the substrate specificity of FALDH towards long-chain fatty aldehydes. Substrate funnel properties and substrate specificity, overview
-
-
?
additional information
?
-
-
the C-terminal gatekeeper helix is important for directing the substrate specificity of FALDH towards long-chain fatty aldehydes. Substrate funnel properties and substrate specificity, overview
-
-
?
additional information
?
-
-
poor substrates: acetaldehyde, propionaldehyde, crotonaldehyde, glutaraldehyde, benzaldehyde, retinaldehyde
-
-
?
additional information
?
-
-
Sjögren-Larsson syndrom is an inherited neurocutaneous disease caused by mutations in the ALDH3A2 gene that codes for fatty aldehyde dehydrogenase, an enzyme involved in lipid metabolism. A rich diversity of mutations and haplotype associations is demonstrated in Sjögren-Larsson syndrom
-
-
?
additional information
?
-
-
catalytically important residues to be involved in alcohol and aldehyde oxidation are Gln-120, Glu-207, Cys-241, Phe-333, Tyr-410 and His-411
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Asthma
A rare case of Sjogren-Larsson syndrome with recurrent pneumonia and asthma.
Breast Neoplasms
Identification of new cancer stem cell markers and signaling pathways in HER?2?positive breast cancer by transcriptome sequencing.
Carcinoma, Hepatocellular
Activation of AMP-kinase by Policosanol Requires Peroxisomal Metabolism.
Carcinoma, Squamous Cell
Association of
Cerebral Palsy
Sjögren-larsson syndrome: a study of clinical symptoms and dermatological treatment in 34 Swedish patients.
Cerebral Palsy
Sjögren-Larsson syndrome: a rare disease of the skin and central nervous system.
Colorectal Neoplasms
ALDH3B2 Polymorphism Is Associated with Colorectal Cancer Susceptibility.
Genetic Diseases, Inborn
Human liver fatty aldehyde dehydrogenase: microsomal localization, purification, and biochemical characterization.
Genetic Diseases, Inborn
Ichthyosis in Sjögren-Larsson syndrome reflects defective barrier function due to abnormal lamellar body structure and secretion.
Ichthyosis
A common deletion mutation in European patients with Sjögren-Larsson syndrome.
Ichthyosis
Abnormal fatty alcohol metabolism in cultured keratinocytes from patients with Sjögren-Larsson syndrome.
Ichthyosis
Compound heterozygous mutations in the ALDH3A2 gene cause Sjögren-Larsson syndrome: a case report.
Ichthyosis
Disorders of phospholipids, sphingolipids and fatty acids biosynthesis: toward a new category of inherited metabolic diseases.
Ichthyosis
Genetic assessment of ten Egyptian patients with Sjögren-Larsson syndrome: expanding the clinical spectrum and reporting a novel ALDH3A2 mutation.
Ichthyosis
Genomic organization and expression of the human fatty aldehyde dehydrogenase gene (FALDH).
Ichthyosis
Ichthyosis in Sjögren-Larsson syndrome reflects defective barrier function due to abnormal lamellar body structure and secretion.
Ichthyosis
Large contiguous gene deletions in Sjögren-Larsson syndrome.
Ichthyosis
Mutations associated with Sjögren-Larsson syndrome.
Ichthyosis
Novel Mutation in Sjogren-Larsson Syndrome Is Associated With Divergent Neurologic Phenotypes.
Ichthyosis
Phenotypic variability among adult siblings with Sjögren-Larsson syndrome.
Ichthyosis
Sjögren-larsson syndrome: a study of clinical symptoms and dermatological treatment in 34 Swedish patients.
Ichthyosis
Sjögren-Larsson syndrome: biochemical defects and follow up in three cases.
Ichthyosis
Sjögren-Larsson syndrome: a rare disease of the skin and central nervous system.
Ichthyosis
Sjögren-Larsson syndrome: Novel mutations in the ALDH3A2 gene in a French cohort.
Ichthyosis
The molecular basis of Sjögren-Larsson syndrome: mutation analysis of the fatty aldehyde dehydrogenase gene.
Ichthyosis
Update on Sjögren-Larsson syndrome.
Intellectual Disability
A common deletion mutation in European patients with Sjögren-Larsson syndrome.
Intellectual Disability
A gatekeeper helix determines the substrate specificity of Sjögren-Larsson Syndrome enzyme fatty aldehyde dehydrogenase.
Intellectual Disability
Abnormal fatty alcohol metabolism in cultured keratinocytes from patients with Sjögren-Larsson syndrome.
Intellectual Disability
Compound heterozygous mutations in the ALDH3A2 gene cause Sjögren-Larsson syndrome: a case report.
Intellectual Disability
Disorders of phospholipids, sphingolipids and fatty acids biosynthesis: toward a new category of inherited metabolic diseases.
Intellectual Disability
Genetic assessment of ten Egyptian patients with Sjögren-Larsson syndrome: expanding the clinical spectrum and reporting a novel ALDH3A2 mutation.
Intellectual Disability
Genomic organization and expression of the human fatty aldehyde dehydrogenase gene (FALDH).
Intellectual Disability
Ichthyosis in Sjögren-Larsson syndrome reflects defective barrier function due to abnormal lamellar body structure and secretion.
Intellectual Disability
Large contiguous gene deletions in Sjögren-Larsson syndrome.
Intellectual Disability
Novel Mutation in Sjogren-Larsson Syndrome Is Associated With Divergent Neurologic Phenotypes.
Intellectual Disability
Phenotypic variability among adult siblings with Sjögren-Larsson syndrome.
Intellectual Disability
Sjögren-larsson syndrome: a study of clinical symptoms and dermatological treatment in 34 Swedish patients.
Intellectual Disability
Sjögren-Larsson syndrome: a rare disease of the skin and central nervous system.
Intellectual Disability
Sjögren-Larsson syndrome: Novel mutations in the ALDH3A2 gene in a French cohort.
Intellectual Disability
The molecular basis of Sjögren-Larsson syndrome: mutation analysis of the fatty aldehyde dehydrogenase gene.
Intellectual Disability
Update on Sjögren-Larsson syndrome.
Leukoencephalopathies
Phenotypic variability among adult siblings with Sjögren-Larsson syndrome.
long-chain-aldehyde dehydrogenase deficiency
Disorders of phospholipids, sphingolipids and fatty acids biosynthesis: toward a new category of inherited metabolic diseases.
long-chain-aldehyde dehydrogenase deficiency
Juvenile macular dystrophy associated with deficient activity of fatty aldehyde dehydrogenase in Sjögren-Larsson syndrome.
long-chain-aldehyde dehydrogenase deficiency
Restoration of fatty aldehyde dehydrogenase deficiency in Sjögren-Larsson syndrome.
long-chain-aldehyde dehydrogenase deficiency
Sjögren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency.
long-chain-aldehyde dehydrogenase deficiency
Understanding fetal factors that contribute to preterm birth: Sjögren-Larsson syndrome as a model.
Macular Degeneration
Juvenile macular dystrophy associated with deficient activity of fatty aldehyde dehydrogenase in Sjögren-Larsson syndrome.
Macular Degeneration
Phenotypic variability among adult siblings with Sjögren-Larsson syndrome.
Muscle Spasticity
Mutations associated with Sjögren-Larsson syndrome.
Muscle Spasticity
Novel Mutation in Sjogren-Larsson Syndrome Is Associated With Divergent Neurologic Phenotypes.
Muscle Spasticity
Sjögren-Larsson syndrome: Novel mutations in the ALDH3A2 gene in a French cohort.
Muscle Spasticity
Update on Sjögren-Larsson syndrome.
Neoplasms
Label-Free Semiquantitative Liquid Chromatography-Tandem Mass Spectrometry Proteomics Analysis of Laryngeal/Hypopharyngeal Squamous Cell Carcinoma on Formalin-Fixed, Paraffin-Embedded Tissue Samples - a Pilot Study.
Nervous System Diseases
Mutations associated with Sjögren-Larsson syndrome.
Neuroblastoma
Involvement of aldehyde dehydrogenase 1A2 in the regulation of cancer stem cell properties in neuroblastoma.
Neurocutaneous Syndromes
5-Lipoxygenase inhibition: a new treatment strategy for Sjögren-Larsson syndrome.
Neurocutaneous Syndromes
A common deletion mutation in European patients with Sjögren-Larsson syndrome.
Neurocutaneous Syndromes
A Turkish family with Sjögren-Larsson syndrome caused by a novel ALDH3A2 mutation.
Neurocutaneous Syndromes
Abnormal fatty alcohol metabolism in cultured keratinocytes from patients with Sjögren-Larsson syndrome.
Neurocutaneous Syndromes
Clinical, biochemical and molecular genetic characteristics of 19 patients with the Sjögren-Larsson syndrome.
Neurocutaneous Syndromes
Compound heterozygous mutations in the ALDH3A2 gene cause Sjögren-Larsson syndrome: a case report.
Neurocutaneous Syndromes
Defective metabolism of leukotriene B4 in the Sjögren-Larsson syndrome.
Neurocutaneous Syndromes
Impaired skin barrier function due to reduced ?-O-acylceramide levels in a mouse model of Sjögren-Larsson syndrome.
Neurocutaneous Syndromes
MRI and 1H-MRS findings of three patients with Sjögren-Larsson syndrome.
Neurocutaneous Syndromes
Restoration of fatty aldehyde dehydrogenase deficiency in Sjögren-Larsson syndrome.
Neurocutaneous Syndromes
Sjögren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency.
Neurocutaneous Syndromes
Sjögren-Larsson syndrome: phenotypic variability in two brothers with a neurocutaneous disorder.
Neurocutaneous Syndromes
Update on Sjögren-Larsson syndrome.
Neurocutaneous Syndromes
[Sjögren-Larsson syndrome: a novel mutation in a Moroccan child]
Paraparesis, Spastic
Phenotypic variability among adult siblings with Sjögren-Larsson syndrome.
Pulmonary Disease, Chronic Obstructive
Prediction of new targets and mechanisms for quercetin in the treatment of pancreatic cancer, colon cancer, and rectal cancer.
Quadriplegia
Disorders of phospholipids, sphingolipids and fatty acids biosynthesis: toward a new category of inherited metabolic diseases.
Quadriplegia
Sjögren-larsson syndrome: a study of clinical symptoms and dermatological treatment in 34 Swedish patients.
Quadriplegia
Sjögren-Larsson syndrome: a rare disease of the skin and central nervous system.
Quadriplegia
Sjögren-Larsson syndrome: Novel mutations in the ALDH3A2 gene in a French cohort.
Quadriplegia
Update on Sjögren-Larsson syndrome.
Sjogren-Larsson Syndrome
5-Lipoxygenase inhibition: a new treatment strategy for Sjögren-Larsson syndrome.
Sjogren-Larsson Syndrome
A common deletion mutation in European patients with Sjögren-Larsson syndrome.
Sjogren-Larsson Syndrome
A novel homozygous missense mutation in the fatty aldehyde dehydrogenase gene causes Sjögren-Larsson syndrome.
Sjogren-Larsson Syndrome
Abnormal fatty alcohol metabolism in cultured keratinocytes from patients with Sjögren-Larsson syndrome.
Sjogren-Larsson Syndrome
Adeno-associated virus vectors are able to restore fatty aldehyde dehydrogenase-deficiency. Implications for gene therapy in Sjogren-Larsson syndrome.
Sjogren-Larsson Syndrome
Bezafibrate induces FALDH in human fibroblasts; implications for Sjögren-Larsson syndrome.
Sjogren-Larsson Syndrome
Characterisation of recombinant human fatty aldehyde dehydrogenase: implications for Sjögren-Larsson syndrome.
Sjogren-Larsson Syndrome
Characterization of the human omega-oxidation pathway for omega-hydroxy-very-long-chain fatty acids.
Sjogren-Larsson Syndrome
Clinical, biochemical and molecular genetic characteristics of 19 patients with the Sjögren-Larsson syndrome.
Sjogren-Larsson Syndrome
Defective metabolism of leukotriene B4 in the Sjögren-Larsson syndrome.
Sjogren-Larsson Syndrome
Disorders of phospholipids, sphingolipids and fatty acids biosynthesis: toward a new category of inherited metabolic diseases.
Sjogren-Larsson Syndrome
Enzymatic diagnosis of Sjögren-Larsson syndrome using electrospray ionization mass spectrometry.
Sjogren-Larsson Syndrome
Fatty aldehyde dehydrogenase: genomic structure, expression and mutation analysis in Sjögren-Larsson syndrome.
Sjogren-Larsson Syndrome
Genomic organization and expression of the human fatty aldehyde dehydrogenase gene (FALDH).
Sjogren-Larsson Syndrome
Human fatty aldehyde dehydrogenase gene (ALDH10): organization and tissue-dependent expression.
Sjogren-Larsson Syndrome
Human liver fatty aldehyde dehydrogenase: microsomal localization, purification, and biochemical characterization.
Sjogren-Larsson Syndrome
Ichthyosis in Sjögren-Larsson syndrome reflects defective barrier function due to abnormal lamellar body structure and secretion.
Sjogren-Larsson Syndrome
Juvenile macular dystrophy associated with deficient activity of fatty aldehyde dehydrogenase in Sjögren-Larsson syndrome.
Sjogren-Larsson Syndrome
Microsomal fatty aldehyde dehydrogenase catalyzes the oxidation of aliphatic aldehyde derived from ether glycerolipid catabolism: implications for Sjögren-Larsson syndrome.
Sjogren-Larsson Syndrome
Monitoring of fatty aldehyde dehydrogenase by formation of pyrenedecanoic acid from pyrenedecanal.
Sjogren-Larsson Syndrome
MRI and 1H-MRS findings of three patients with Sjögren-Larsson syndrome.
Sjogren-Larsson Syndrome
Mutations associated with Sjögren-Larsson syndrome.
Sjogren-Larsson Syndrome
Novel and recurrent ALDH3A2 mutations in Italian patients with Sjögren-Larsson syndrome.
Sjogren-Larsson Syndrome
Phenotypic variability among adult siblings with Sjögren-Larsson syndrome.
Sjogren-Larsson Syndrome
Pre- and postnatal growth retardation, scaling skin, moderate mental retardation and quadrispasticity, hypospadias grade 2 and hydro-uretero nephrosis, postaxial polydactyly. A distinct MCA/MR syndrome?
Sjogren-Larsson Syndrome
Restoration of fatty aldehyde dehydrogenase deficiency in Sjögren-Larsson syndrome.
Sjogren-Larsson Syndrome
Sjögren-Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene.
Sjogren-Larsson Syndrome
Sjögren-Larsson syndrome.
Sjogren-Larsson Syndrome
Sjögren-Larsson syndrome. Deficient activity of the fatty aldehyde dehydrogenase component of fatty alcohol:NAD+ oxidoreductase in cultured fibroblasts.
Sjogren-Larsson Syndrome
Sjögren-larsson syndrome: a study of clinical symptoms and dermatological treatment in 34 Swedish patients.
Sjogren-Larsson Syndrome
Sjögren-Larsson syndrome: biochemical defects and follow up in three cases.
Sjogren-Larsson Syndrome
Sjögren-Larsson syndrome: diversity of mutations and polymorphisms in the fatty aldehyde dehydrogenase gene (ALDH3A2).
Sjogren-Larsson Syndrome
Sjögren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency.
Sjogren-Larsson Syndrome
Sjögren-Larsson syndrome: seven novel mutations in the fatty aldehyde dehydrogenase gene ALDH3A2.
Sjogren-Larsson Syndrome
Sjogren-Larsson syndrome: A rare neurocutaneous disorder.
Sjogren-Larsson Syndrome
Sjogren-Larsson Syndrome: Mechanisms and Management.
Sjogren-Larsson Syndrome
Sjögren-Larsson syndrome: Novel mutations in the ALDH3A2 gene in a French cohort.
Sjogren-Larsson Syndrome
Spectrum of mutations and sequence variants in the FALDH gene in patients with Sjögren-Larsson syndrome.
Sjogren-Larsson Syndrome
The molecular basis of Sjögren-Larsson syndrome: mutation analysis of the fatty aldehyde dehydrogenase gene.
Sjogren-Larsson Syndrome
Understanding fetal factors that contribute to preterm birth: Sjögren-Larsson syndrome as a model.
Sjogren-Larsson Syndrome
Update on Sjögren-Larsson syndrome.
Sjogren-Larsson Syndrome
[Sjögren-Larsson syndrome: a novel mutation in a Moroccan child]
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Kelson, T.L.; Secor McVoy, J.R.; Rizzo, W.B.
Human liver fatty aldehyde dehydrogenase: microsomal localization, purification, and biochemical characterization
Biochim. Biophys. Acta
1335
99-110
1997
Homo sapiens
brenda
Carney, G.; Wei, S.; Rizzo, W.B.
Sjogren-Larsson syndrome: seven novel mutations in the fatty aldehyde dehydrogenase gene ALDH3A2
Hum. Mutat.
24
186
2004
Homo sapiens
brenda
van den Brink, D.M.; van Miert, J.N.; Dacremont, G.; Rontani, J.F.; Jansen, G.A.; Wanders, R.J.
Identification of fatty aldehyde dehydrogenase in the breakdown of phytol to phytanic acid
Mol. Genet. Metab.
82
33-37
2004
Homo sapiens
brenda
Rizzo, W.B.; Carney, G.
Sjoegren-Larsson syndrome: diversity of mutations and polymorphisms in the fatty aldehyde dehydrogenase gene (ALDH3A2)
Hum. Mutat.
26
1-10
2005
Homo sapiens
brenda
Gloerich, J.; Ijlst, L.; Wanders, R.J.; Ferdinandusse, S.
Bezafibrate induces FALDH in human fibroblasts; implications for Sjoegren-Larsson syndrome
Mol. Genet. Metab.
89
111-115
2006
Homo sapiens
brenda
Rizzo, W.B.
Sjoegren-Larsson syndrome: Molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency
Mol. Genet. Metab.
90
1-9
2007
Homo sapiens
brenda
Lloyd, M.D.; Boardman, K.D.; Smith, A.; van den Brink, D.M.; Wanders, R.J.; Threadgill, M.D.
Characterisation of recombinant human fatty aldehyde dehydrogenase: implications for Sjoegren-Larsson syndrome
J. Enzyme Inhib. Med. Chem.
22
584-590
2007
Homo sapiens
brenda
Kitamura, T.; Naganuma, T.; Abe, K.; Nakahara, K.; Ohno, Y.; Kihara, A.
Substrate specificity, plasma membrane localization, and lipid modification of the aldehyde dehydrogenase ALDH3B1
Biochim. Biophys. Acta
1831
1395-1401
2013
Homo sapiens
brenda
Keller, M.; Watschinger, K.; Golderer, G.; Maglione, M.; Sarg, B.; Lindner, H.; Werner-Felmayer, G.; Terrinoni, A.; Wanders, R.; Werner, E.
Monitoring of fatty aldehyde dehydrogenase by formation of pyrenedecanoic acid from pyrenedecanal
J. Lipid Res.
51
1554-1559
2010
Homo sapiens, Mus musculus, Rattus norvegicus
brenda
Keller, M.A.; Zander, U.; Fuchs, J.E.; Kreutz, C.; Watschinger, K.; Mueller, T.; Golderer, G.; Liedl, K.R.; Ralser, M.; Kraeutler, B.; Werner, E.R.; Marquez, J.A.
A gatekeeper helix determines the substrate specificity of Sjoegren-Larsson Syndrome enzyme fatty aldehyde dehydrogenase
Nat. Commun.
5
4439
2014
Homo sapiens (P51648), Homo sapiens
brenda